Condition
Paraplegia, Incomplete
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06939634Completed
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
NCT06708962Not ApplicableCompletedPrimary
Effect of Mulligan's Mobilization on Shoulder Joint Range of Motion and Subacromial Space in Paraplegic Patients
NCT06272279Not ApplicableRecruiting
Neuromodulation With Spinal Stimulation Methods
NCT04453943Not ApplicableUnknown
Modeling, Optimization, and Control Methods for a Personalized Hybrid Walking Exoskeleton
Showing all 4 trials